The protein Z/protein Z-dependent protease inhibitor complex

Area of Science:

• Biochemistry
• Hematology
• Molecular Biology

Background:

• Protein Z (PZ) is a vitamin K-dependent plasma factor without enzymatic activity.
• PZ functions as a cofactor for protein Z-dependent protease inhibitor (ZPI), forming a complex that inhibits activated factor X.
• Gene disruption studies in mice suggest a role for PZ and ZPI in thrombosis, though clinical data remains inconclusive.

Purpose of the Study:

• To review the current understanding of Protein Z and ZPI.
• To evaluate the clinical significance of PZ deficiency in thrombosis and fetal loss.
• To explore the potential roles of PZ and ZPI in kidney and cancer cells.

Main Methods:

• Literature review and meta-analysis of existing clinical studies.
• Analysis of gene disruption studies in murine models.
• Review of recent findings on PZ and ZPI synthesis in various cell types.

Main Results:

• Conflicting results exist regarding PZ deficiency as a risk factor for thrombosis and fetal loss.
• A recent meta-analysis suggests a potential link, but limitations in study size and design are noted.
• PZ and ZPI are synthesized in normal kidney and cancer cells, hinting at a role in inhibiting fibrin deposition.

Conclusions:

• The clinical utility of measuring plasma PZ and ZPI or their gene polymorphisms for thrombophilia assessment is currently not established.
• Further research is required to elucidate the physiopathological consequences of PZ and ZPI synthesis in non-hepatic tissues.
• The role of PZ and ZPI in thrombosis and fetal loss requires more robust clinical investigation.